It has been proposed that visfatin production might potentially be low in the lean state and that intra-abdominal obesity leads to increased visfatin production, which simultaneously increases with obesity, but also changes the properties of visfatin, giving it more insulin-mimetic qualities (15). This evidence concerns the gene NAMPT and Obesity.